Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

APRE stock hub

Aprea Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

APREis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

APRE

In the news

Latest news · APRE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-74.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-49

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All APRE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001781983
Company name	Aprea Therapeutics, Inc.
Country	United States
Country code	US
Cusip	03836J102
Employees	8
Employees Change	1%
Employees Change Percent	14.29
Enterprise value	$-2.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-10-03
Isin	US03836J2015
Last refreshed	2026-05-10
Market cap	$11.7M
Market cap category	Nano-Cap
Price	$0.98
Price currency	USD
Rev Per Employee	35,719.88x
Sector	Healthcare
Sic	2834
Symbol	APRE
Website	https://aprea.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-107.3%
FCF yield	-109.82%
P/B ratio	0.65x
P/S ratio	41.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-6.8M
Net Income	$-12.6M
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Pretax Margin	-4,409.16%
Profit Per Employee	$-1.6M
ROA	-41.45
ROCE	-100.5
ROE	-74.58
ROIC	-48.96

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-41.69%
Cagr3y	-36.89%
EPS Growth Quarters	8
EPS Growth Years	3
Revenue Growth	-80.98x
Revenue Growth Q	-98.38x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$15.9M
Cash	$14.6M
Current Assets	$15.6M
Current Liabilities	$2.8M
Equity	$13.2M
Liabilities	$2.8M
Long Term Assets	$372,155
Long Term Liabilities	$0
Net Cash	$14.6M
Net Cash By Market Cap	$124
Net Cash Growth	-36.11%
Net Debt Equity	$-1.11
Tangible Book Value	$12.4M
Tangible Book Value Per Share	$1.52
WACC	12.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.63
Net Working Capital	$-1.8M
Quick ratio	5.28
Working Capital	$12.8M
Working Capital Turnover	$0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-18.67%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-41.67%
200-day SMA	1.13
3Y total return	-74.87%
50-day SMA	0.82
50-day SMA vs 200-day SMA	50under200
All Time High	25.8
All Time High Change	-96.2%
All Time High Date	2022-07-19
All Time Low	0.55
All Time Low Change	78.81%
All Time Low Date	2026-01-29
ATR	0.09
Beta	1.52
Beta1y	3.22
Beta2y	2.03
Ch YTD	14.88
High	1.06
High52	2.22
High52 Date	2025-07-23
High52ch	-55.86%
Low	0.9
Low52	0.55
Low52 Date	2026-01-29
Low52ch	78.81%
Ma50ch	19.38%
Premarket Change Percent	4.92
Premarket Price	$0.92
Premarket Volume	7,562
Price vs 200-day SMA	-13.59%
RSI	62.1
RSI Monthly	33.77
RSI Weekly	49
Sharpe ratio	-0.22x
Sortino ratio	-0.28
Total Return	-18.67%
Tr YTD	14.88
Tr1m	37.82%
Tr1w	19.79%
Tr3m	42.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.23
Operating Income	$-13.2M
Operating margin	-4,631.1
Price target	$4.4
Price Target Change	$349

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,295,353%
Float Percent	69.23%
Shares Insiders	11.69%
Shares Institutions	11.07%
Shares Out	11,982,776
Shares Qo Q	20.63%
Shares Yo Y	18.67%
Short Float	1.32%
Short Ratio	0.16
Short Shares	0.92

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-13.4M
Average Volume	298,669.75x
Bv Per Share	1.52
Ch1m	37.82
Ch1w	19.79
Ch1y	-41.67
Ch3m	42.01
Ch3y	-74.87
Ch6m	-20.33
Change	11.26%
Change From Open	5.37
Close	0.88
Days Gap	5.6
Depreciation Amortization	21,715
Dollar Volume	954,950.8
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-13.2M
EBITDA	$-13.2M
EPS	$-1.93
F Score	0
FCF	$-12.9M
FCF EV Yield	451.26x
FCF Per Share	$-1.08
Financing CF	4,640,238
Fiscal Year End	December
Founded	2,006
Ipr	-93.47
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-16
Last Report Date	2025-12-31
Last Split Date	2023-02-13
Last Split Type	Reverse
Last10k Filing Date	2026-03-16
Ma150	0.98
Ma150ch	0.29%
Ma20	0.89
Ma20ch	10.08%
Net CF	-8,249,522
Next Earnings Date	2026-05-22
Open	0.93
Optionable	No
Position In Range	49.08
Post Close	0.98
Postmarket Change Percent	-1.99
Postmarket Price	$0.96
Ppne	59,807
Pre Close	0.88
Price Date	2026-05-08
Ptbv Ratio	0.94
Relative Volume	3.26x
Revenue	285,759x
SBC By Revenue	180.99x
Share Based Comp	517,191
Tr6m	-20.33%
Us State	Pennsylvania
Volume	974,539
Z Score	-28.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does APRE pay a dividend?

Capital-return profile for this ticker.

Performance

APRE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns APRE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.1%

Float: +69.2% of shares outstanding

Insider ownership

+11.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

APRE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.1

Neutral momentum band

Price vs 200-day MA

-13.6%

50/200-day relationship not available

Beta (5Y)

1.52

More volatile than the market

Sharpe ratio

-0.22

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About APRE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current APRE stock rating?

Aprea Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full APRE analysis?

The full report lives at /stocks/APRE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for APRE?

The latest report frames APRE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the APRE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.